UPDATE 1-Obagi Medical gets higher offer from Merz Pharma
April 02, 2013 at 08:37 AM EDT
April 2 (Reuters) - Neurological and dermatology drugs maker Merz Pharma Group offered to buy cosmetic products maker Obagi Medical Products Inc for $383.5 million, topping a bid by Canada's Valeant Pharmaceuticals International Inc .
